Allergy Treatment Composition Using Ganoderma and Cordyceps
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current compositions do not effectively prevent and treat allergic diseases, despite the known benefits of ingredients like Ganoderma, Radix Panacis Quinquefolii, Radix Et Rhizoma Ginseng, fermented Cordyceps sinensis powder, and Cordyceps in traditional medicine, as no reports have shown their efficacy in addressing allergic conditions.
Innovation Solution
A composition combining Ganoderma, Radix Panacis Quinquefolii or Radix Et Rhizoma Ginseng, fermented Cordyceps sinensis powder, and Flos Rosae Rugosae, with optional additives like Ganoderma spore powder, Radix Pseudostellariae, Folium Ginseng, Radix Codonopsis, and Radix Astragali, is developed for use in healthcare products and medicaments to treat allergic diseases.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If traditional compositions containing Ganoderma, Radix Panacis Quinquefolii, Radix Et Rhizoma Ginseng, fermented Cordyceps sinensis powder, and/or Cordyceps are used, then immunity enhancement and anti-fatigue effects are achieved, but allergic disease prevention and treatment effects are not obtained
Solution Approach 1:
The patent extends the functional scope of traditional compositions by demonstrating that the combination of Ganoderma, Radix Panacis Quinquefolii or Radix Et Rhizoma Ginseng, fermented Cordyceps sinensis powder and/or Cordyceps, and Flos Rosae Rugosae can achieve multiple therapeutic effects including both traditional immunity enhancement and novel allergic disease prevention and treatment, making the composition universally applicable for both immunomodulation and allergy management
Solution Approach 2:
The patent creates a composite medicinal composition by combining five specific traditional Chinese medicine materials (Ganoderma, Radix Panacis Quinquefolii or Radix Et Rhizoma Ginseng, fermented Cordyceps sinensis powder and/or Cordyceps, and Flos Rosae Rugosae) in specific weight ratios to achieve synergistic effects that address allergic diseases, which neither the individual components nor previous combinations could accomplish
2Reliability
If existing medicaments are used for allergic diseases, then treatment is provided, but compositions that specifically target passive anaphylaxis, delayed hypersensitivity, and capillary permeability are lacking
Solution Approach 1:
The patent optimizes the weight ratios of each component in the composition (Ganoderma: 5-200 parts, Radix Panacis Quinquefolii or Radix Et Rhizoma Ginseng: 5-150 parts, fermented Cordyceps sinensis powder and/or Cordyceps: 1-120 parts, Flos Rosae Rugosae: 5-90 parts) to achieve maximum efficacy in inhibiting passive anaphylaxis, delayed hypersensitivity, and capillary permeability while maintaining formulation feasibility
Data Source
AI summary
The present invention relates to use of a composition in the manufacture of health care products or medicaments for prevention and treatment of allergic diseases. The composition is made from raw materials comprising 5 to 200 parts by weight of Ganoderma, 5 to 150 parts by weight of Radix Panacis Quinquefolii or Radix Et Rhizoma Ginseng, 1 to 90 parts by weight of fermented Cordyceps sinensis powder and/or 1 to 120 parts by weight of Cordyceps, or is a composition made from water and/or alcohol extracts of the above raw materials as active components. The allergic diseases include allergic rhinitis, allergic dermatitis, urticaria, and/or allergic asthma.